Response: Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: A modeling analysis

Daniel F. Hayes, Vered Stearns, James Rae, David Flockhart

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1333-1334
Number of pages2
JournalJournal of the National Cancer Institute
Volume100
Issue number18
DOIs
StatePublished - Sep 2008

Fingerprint

Cytochrome P-450 CYP2D6
Pharmacogenetics
Breast Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Response : Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: A modeling analysis. / Hayes, Daniel F.; Stearns, Vered; Rae, James; Flockhart, David.

In: Journal of the National Cancer Institute, Vol. 100, No. 18, 09.2008, p. 1333-1334.

Research output: Contribution to journalArticle

@article{bd569f80e7e44aefba8875e51fbc31b7,
title = "Response: Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: A modeling analysis",
author = "Hayes, {Daniel F.} and Vered Stearns and James Rae and David Flockhart",
year = "2008",
month = "9",
doi = "10.1093/jnci/djn271",
language = "English",
volume = "100",
pages = "1333--1334",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "18",

}

TY - JOUR

T1 - Response

T2 - Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: A modeling analysis

AU - Hayes, Daniel F.

AU - Stearns, Vered

AU - Rae, James

AU - Flockhart, David

PY - 2008/9

Y1 - 2008/9

UR - http://www.scopus.com/inward/record.url?scp=52449096960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52449096960&partnerID=8YFLogxK

U2 - 10.1093/jnci/djn271

DO - 10.1093/jnci/djn271

M3 - Article

AN - SCOPUS:52449096960

VL - 100

SP - 1333

EP - 1334

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 18

ER -